Heidrick & Struggles (HSII) Tops Q3 EPS by 26c, Offers Guidance
Get Alerts HSII Hot Sheet
Price: $59.01 --0%
Financial Fact:
Revenue before reimbursements (net revenue): 143.52M
Today's EPS Names:
OTLK, EGRX, MOVE, More
Financial Fact:
Revenue before reimbursements (net revenue): 143.52M
Today's EPS Names:
OTLK, EGRX, MOVE, More
Join SI Premium – FREE
Heidrick & Struggles (NASDAQ: HSII) reported Q3 EPS of $1.11, $0.26 better than the analyst estimate of $0.85. Revenue for the quarter came in at $268.3 million versus the consensus estimate of $251.58 million.
GUIDANCE:
Heidrick & Struggles sees Q4 2021 revenue of $255-265 million, versus the consensus of $228.6 million.
- The Company expects 2021 fourth quarter consolidated net revenue of between $255 million and $265 million, while acknowledging that the continued fluidity of the COVID-19 pandemic may impact quarterly results. In addition, this outlook is based on the average currency rates in September 2021 and reflects, among other factors, management's assumptions for the anticipated volume of new Executive Search confirmations, Heidrick Consulting assignments, On-Demand Talent projects and the current backlog, consultant productivity, consultant retention, and the seasonality of its business.
For earnings history and earnings-related data on Heidrick & Struggles (HSII) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- SanDisk upgraded at JPMorgan after investor day; shares climb
- Tvardi Therapeutics (TVRD) Tops Q2 EPS by 1c
- Outlook Therapeutics (OTLK) Misses Q3 EPS by 9c
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share